JOURNAL OF CLINICAL SURGERY ›› 2022, Vol. 30 ›› Issue (7): 673-676.doi: 10.3969/j.issn.1005-6483.2022.07.022

Previous Articles     Next Articles

Relationship between circulating miR-485-5p and pathological parameters in patients with prostate cancer and its prognostic value

  

  1. Department of Urology,Huai'an Hospital Affiliated to Xuzhou Medical University,Huaian Second People's Hospital,Jiangsu,Huai'an 223000,China
  • Received:2022-01-24 Accepted:2022-01-24 Online:2022-07-20 Published:2022-07-20

Abstract: Objective To explore the relationship between circulating miR-485-5p levels and pathological parameters of prostate cancer patients and its prognostic value. Methods A prospective study was conducted on 103 patients with prostate cancer admitted to the hospital from October 2016 to November 2018.All patients underwent radical surgery for prostate cancer and were followed up for 3 years.The relative expression of miR-485-5p was detected in all patients before operation.The relative expression of miR-485-5p in serum of prostate cancer patients with different pathological parameters was analyzed.Factors affecting the recurrence and metastasis of prostate cancer patients were analyzed.The value of serum miR-485-5p relative expression in predicting postoperative recurrence and metastasis of prostate cancer patients was analyzed.The relationship between the relative expression of miR-485-5p and the prognosis of prostate cancer patients was analyzed. Results The relative expression of miR-485-5p in patients with Gleason score>7,microvascular invasion,lymph node metastasis,and stage Ⅲ was lower than Gleason score ≤7 points,no microvascular invasion,no lymph node metastasis,and stage Ⅰ-Ⅱ(P<0.05).As of the end of follow-up,10 patients were lost to follow-up,and 35 of the remaining 93 prostate cancer patients had recurrence and metastasis.Cox regression analysis showed Gleason score,stage,relative expression of miR-485-5p was independent factor affecting postoperative recurrence and metastasis of prostate cancer patients(P<0.05).ROC curve results showed that the sensitivity of serum miR-485-5p level to predict postoperative recurrence and metastasis of prostate cancer patients was 74.29%,and the specificity was 75.86%,AUC was 0.795.The best cut-off point(1.02) for predicting postoperative recurrence and metastasis of prostate cancer patients with the relative expression of preoperative serum miR-485-5p is the dividing line.41 patients with low miR-485-5p expression survived 21 patients,and 52 patients with high miR-485-5p expression survived 37 patients;patients with high miR-485-5p expression had better disease-free survival curves than miR-485 For patients with low expression of -5p(P<0.05). Conclusion The expression of miR-485-5p is related to the pathological parameters and prognosis of prostate cancer patients.Patients with low miR-485-5p expression have a high risk of poor prognosis.

Key words: prostate cancer, miR-485-5p, pathology, prognosis

[1] YUAN Ye, LIU Tao, LIU Hua. Relationship between the expression levels of microRNA-138 and microRNA-145 and Th1/Th2 drift and prognosis in esophageal squamous cell carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(8): 744-748.
[2] LUO Yaobing, YANG Wujun, WANG Xingping, et al. Effect of stepped decompression under intracranial pressure monitoring on inflammatory response,metabolic status and prognosis of patients with emergency craniocerebral trauma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(7): 640-643.
[3] YUAN Zhao, ZHENG Ang. Analysis of clinical efficacy hemodynamic indexes and prognosis of laparoscopic splenectomy and EVLS therapy in the treatment ofportal hypertension patients [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(7): 691-693.
[4] LI Zongfu, CHEN Tieliang, DING Mei, et al. Analysis of the effect of rapid rehabilitation surgery on the nutritional status of patients undergoing laparoscopic-assisted pyloric sparing gastrectomy for early gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 433-436.
[5] RUAN Tian, LI Changsheng, YANG Zetian, et al. The effect of visceral pleural invasion on the survival of postoperative patients with stage ⅢA/N2 non-small cell lung cancer:SEER database analysis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 448-452.
[6] YE Bin, XIANG Qiu, JIN Wenjie. Expression of forkhead box Q1 and CyclinD1 in non-small cell lung cancer and their relationship with clinicopathological features and prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 453-458.
[7] BIAN Chunan, TIAN Xiaoqi, LIN Chaoyu, et al. Differentiated expression and clinical significance of crystallin-alpha B in lung squamous cell carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 486-489.
[8] YANG Heng, ZHANG Jun, GUO Qiang, et al. The potential value of HLA-DPB1 in lung adenocarcinoma was analyzed based on multi-database [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 339-344.
[9] JIN Yi , WANG Xinyi, DU Runsen, et al. Decreased expression of hsa-mir-337 predicts poor prognosis in patients with breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 345-348.
[10] WANG Pengyuan, SHANG Yichao, ZHENG Duo, et al. Prognostic analysis of pelvis and ureteral carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 368-371.
[11] LU Kaijin, SHEN Jiangfeng, JIA Weiguang. Effect of thoracoscopic modified recurrent laryngeal nerve lymph node dissection for esophageal cancer and its effect on patient prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 257-260.
[12] SHEN Jian, LI Minzhe, DU Yanfu. Effect of central obesity on clinical efficacy of laparoscopic D2 radical gastrectomy for distal gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 261-265.
[13] LI Yuzhu, XIA Lianjie. Expression of Dickkopfrelated protein 2 in cancer tissues of patients with bladder cancer and its correlation with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 280-283.
[14] JI Jintao, KANG Bo, SU Yansheng. Relationship between prostate specific membrane antigen expression and clinicopathological features in prostate cancer patients and its prognostic value [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 130-133.
[15] LI Yunlong, DU Zhenghua, ZHANG Huimin, et al. Clinical treatment and prognostic analysis of gastrointestinal pancreatic neuroendocrine neoplasm [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 166-170.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 744 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 764 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 766 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 769 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 772 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 774 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 783 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 787 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 789 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 792 .